149 related articles for article (PubMed ID: 36183022)
1. Optimization of an adenovirus-vectored zoster vaccine production process with chemically defined medium and a perfusion system.
Nie J; Sun Y; Ren H; Huang L; Feng K; Li Y; Bai Z
Biotechnol Lett; 2022 Nov; 44(11):1347-1358. PubMed ID: 36183022
[TBL] [Abstract][Full Text] [Related]
2. The efficient development of a novel recombinant adenovirus zoster vaccine perfusion production process.
Nie J; Sun Y; Feng K; Huang L; Li Y; Bai Z
Vaccine; 2022 Mar; 40(13):2036-2043. PubMed ID: 35216843
[TBL] [Abstract][Full Text] [Related]
3. Application of Multivariate Data Analysis on Historical Recombinant Adenovirus Zoster Vaccine Production Data for Upstream Process Improvements.
Nie J; Ren H; Sun Y; Li Y; Zhang Y; Bai Z
J Pharm Sci; 2024 May; 113(5):1168-1176. PubMed ID: 38447668
[TBL] [Abstract][Full Text] [Related]
4. Development of a perfusion process for serum-free adenovirus vector herpes zoster vaccine production.
Sun Y; Huang L; Nie J; Feng K; Liu Y; Bai Z
AMB Express; 2022 May; 12(1):58. PubMed ID: 35567723
[TBL] [Abstract][Full Text] [Related]
5. High-cell-density cultivations to increase MVA virus production.
Vázquez-Ramírez D; Genzel Y; Jordan I; Sandig V; Reichl U
Vaccine; 2018 May; 36(22):3124-3133. PubMed ID: 29433897
[TBL] [Abstract][Full Text] [Related]
6. A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor.
Rourou S; van der Ark A; Majoul S; Trabelsi K; van der Velden T; Kallel H
Appl Microbiol Biotechnol; 2009 Nov; 85(1):53-63. PubMed ID: 19521697
[TBL] [Abstract][Full Text] [Related]
7. [Hyperosmotic stress and perfusion culture strategies increase the yield of recombinant adenoviral vector produced by HEK 293 cells].
Zhang Z; Bai Z; Liu G; Nie J; Yang Y
Sheng Wu Gong Cheng Xue Bao; 2023 Aug; 39(8):3364-3378. PubMed ID: 37622366
[TBL] [Abstract][Full Text] [Related]
8. A protocol to transfer a fed-batch platform process into semi-perfusion mode: The benefit of automated small-scale bioreactors compared to shake flasks as scale-down model.
Janoschek S; Schulze M; Zijlstra G; Greller G; Matuszczyk J
Biotechnol Prog; 2019 Mar; 35(2):e2757. PubMed ID: 30479066
[TBL] [Abstract][Full Text] [Related]
9. Optimization and scale-up of cell culture and purification processes for production of an adenovirus-vectored tuberculosis vaccine candidate.
Shen CF; Jacob D; Zhu T; Bernier A; Shao Z; Yu X; Patel M; Lanthier S; Kamen A
Vaccine; 2016 Jun; 34(29):3381-7. PubMed ID: 27154390
[TBL] [Abstract][Full Text] [Related]
10. Development of a measles vaccine production process in MRC-5 cells grown on Cytodex1 microcarriers and in a stirred bioreactor.
Trabelsi K; Majoul S; Rourou S; Kallel H
Appl Microbiol Biotechnol; 2012 Feb; 93(3):1031-40. PubMed ID: 21935589
[TBL] [Abstract][Full Text] [Related]
11. Pseudorabies virus production using a serum-free medium in fixed-bed bioreactors with low cell inoculum density.
Nie J; Sun Y; Peng F; Han F; Yang Y; Liu X; Liu C; Li Y; Bai Z
Biotechnol Lett; 2020 Dec; 42(12):2551-2560. PubMed ID: 32816175
[TBL] [Abstract][Full Text] [Related]
12. A high-yield and scaleable adenovirus vector production process based on high density perfusion culture of HEK 293 cells as suspended aggregates.
Liu H; Liu XM; Li SC; Wu BC; Ye LL; Wang QW; Chen ZL
J Biosci Bioeng; 2009 May; 107(5):524-9. PubMed ID: 19393552
[TBL] [Abstract][Full Text] [Related]
13. Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactor.
Meghrous J; Aucoin MG; Jacob D; Chahal PS; Arcand N; Kamen AA
Biotechnol Prog; 2005; 21(1):154-60. PubMed ID: 15903253
[TBL] [Abstract][Full Text] [Related]
14. Process optimization for the rapid production of adenoviral vectors for clinical trials in a disposable bioreactor system.
Chen KD; Wu XX; Yu DS; Ou HL; Li YH; Zhou YQ; Li LJ
Appl Microbiol Biotechnol; 2018 Aug; 102(15):6469-6477. PubMed ID: 29858958
[TBL] [Abstract][Full Text] [Related]
15. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor.
Trabelsi K; Rourou S; Loukil H; Majoul S; Kallel H
J Biotechnol; 2006 Jan; 121(2):261-71. PubMed ID: 16153733
[TBL] [Abstract][Full Text] [Related]
16. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
Rourou S; van der Ark A; van der Velden T; Kallel H
Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
[TBL] [Abstract][Full Text] [Related]
17. Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems.
Coronel J; Behrendt I; Bürgin T; Anderlei T; Sandig V; Reichl U; Genzel Y
Vaccine; 2019 Nov; 37(47):7011-7018. PubMed ID: 31266669
[TBL] [Abstract][Full Text] [Related]
18. Scalable Lentiviral Vector Production Using Stable HEK293SF Producer Cell Lines.
Manceur AP; Kim H; Misic V; Andreev N; Dorion-Thibaudeau J; Lanthier S; Bernier A; Tremblay S; Gélinas AM; Broussau S; Gilbert R; Ansorge S
Hum Gene Ther Methods; 2017 Dec; 28(6):330-339. PubMed ID: 28826344
[TBL] [Abstract][Full Text] [Related]
19. High-titer adenovirus vector production in 293S cell perfusion culture.
Cortin V; Thibault J; Jacob D; Garnier A
Biotechnol Prog; 2004; 20(3):858-63. PubMed ID: 15176892
[TBL] [Abstract][Full Text] [Related]
20. [Producing Ad-IFN gamma by suspension culture of HEK293 cells in a disposable bioreactor].
Wu Q; Huang W
Sheng Wu Gong Cheng Xue Bao; 2014 Nov; 30(11):1786-90. PubMed ID: 25985530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
